Search

​On May 18, 2023, the Supreme Court unanimously affirmed the Federal Circuit's decision, Amgen Inc. v. Sanofi, 987 F.3d 1080 (Fed. Cir. 2021), that the claims of two of Amgen's patents were invalid for lack enablement. The involved patents, US 8,829,165 and US 8,859,741, are directed to monoclonal...

If you are the owner or co-owner of a small to medium-size medical practice, dental practice, or other health care concern, you have probably never thought of your practice as the type of vehicle that can be used to launder money—not much revenue in the form of cash, too much regulatory oversight...